Home > M&A deals 2026 > XenoTherapeutics, Inc. acquires Repare Therapeutics, Inc.
Add-on Acquistion · Life Science · January 2026

XenoTherapeutics, Inc. acquires Repare Therapeutics, Inc.

On January 28, 2026, XenoTherapeutics, Inc. acquired Repare Therapeutics, Inc., a life science company in Quebec, Canada.

Deal at a glance

AnnouncedJanuary 28, 2026 TypeAdd-on Acquistion TargetRepare Therapeutics, Inc. Buyer XenoTherapeutics, Inc. SectorLife Science LocationQuebec, Canada ValueNot disclosed

Target company

Repare Therapeutics, Inc.
Quebec, Canada
Repare Therapeutics Inc. is a clinical-stage biotechnology company focused on the discovery and development of targeted cancer therapies based on synthetic lethality approaches. The company conducts research and development activities aimed at identifying p...
Life Sciencesector
2016founded
Activestatus
View the company profile →

Buyer

XenoTherapeutics, Inc.
Company · 1 deal on record
  • 1st transaction in life science
  • 1st transaction in Canada
1deals, all time
1in this sector
2026latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

LSK Technologies, Inc.Same sector and country · May 2022
A&L Canada Laboratories, Inc.Same sector and country · May 2022
Hogan Pharmacy Partners Ltd.Same sector and country · Mar 2022

Questions about this deal

Who acquired Repare Therapeutics, Inc.?XenoTherapeutics, Inc. acquired Repare Therapeutics, Inc. on January 28, 2026.

What type of deal was it?It was a add-on acquistion in the life science sector in 2026.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Source: company press release, January 28, 2026 · Data updated daily on AcquityData (Acquity Data).